a few people working at a table

Press Releases

Ladenburg Acts as Exclusive Placement Agent and Exclusive Warrant Solicitation Agent in $5.3 Million Offering for NovaBay Pharmaceuticals, Inc.

Transaction Information NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announced it has entered into a...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Palisade Bio, Inc. in its $13.8 Million Underwritten Public Offering

Transaction Information Palisade Bio, Inc. (Nasdaq: PALI) announced the closing of its previously announced...

Ladenburg Thalmann Acts as Exclusive Financial Advisor to Phosphorex's Majority Acquisition by Ampersand Capital Partners

Transaction Information Phosphorex Inc. announced a majority acquisition by Ampersand Capital Partners, a...

Ladenburg Thalmann Acts as Exclusive Warrant Inducement Agent in Ra Medical's (RMED) $6.2M Warrant Repricing and Announces Strategic Merger Plans with Catheter Precision Inc.

Transaction Information Ra Medical Systems, Inc. (NYSE American: RMED) ("Ra Medical" or the "Company") announced...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Kiora Pharmaceuticals, Inc. in its $6.0 Million Underwritten Public Offering

Transaction Information Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced the closing of an underwritten...

Ladenburg Thalmann Acts as Exclusive Financial Advisor to Athenex, Inc. (Nasdaq: ATNX) in its $85 Million Royalty Monetization

Transaction Information Athenex, Inc. (NASDAQ: ATNX, "Athenex", or "the Company) is a global biopharmaceutical...

Ladenburg Thalmann Acts as Exclusive Placement Agent for Vallon Pharmaceuticals, Inc. (VLON) in its $3.9 Million Registered Direct Offering

Transaction Information Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) announced that it has entered into...

Ladenburg Thalmann acted as Lead Bookrunner for Saratoga Investment Corp. on its $87.5 million offering of Unsecured Notes

Transaction Information New York, NY - Saratoga Investment Corp. (NYSE:SAR) (the "Company") announced that it...

Ladenburg Thalmann Acts as Co-Lead Manager for SCYNEXIS, Inc. (SCYX) in its $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants

Transaction Information SCYNEXIS, Inc. (Nasdaq: SCYX) announced the closing of its previously announced...